Several studies have shown that the inhibition of FASN can lead to the compensatory upregulation of CD36 expression and that inhibiting both pathways is lethal to cancer cells, highlighting the essentiality of FA pool maintenance in cancer [53,62,65]. The gene discussed is FASN; the disease is cancer.